Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
7,280,546
-
Share change
-
+444,730
-
Total reported value
-
$238,830,760
-
Put/Call ratio
-
190%
-
Price per share
-
$32.82
-
Number of holders
-
105
-
Value change
-
+$14,353,157
-
Number of buys
-
36
-
Number of sells
-
56
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2021
As of 30 Sep 2021,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,280,546 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, THOMPSON SIEGEL & WALMSLEY LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, FIRST WILSHIRE SECURITIES MANAGEMENT INC, GOLDMAN SACHS GROUP INC, FEDERATED HERMES, INC., and AMERIPRISE FINANCIAL INC.
This page lists
105
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.